H
Hautarztpraxis Mortazawi | Remscheid, Germany
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Rocatinlimab
AMG 451
Guselkumab
JNJ-77242113
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
The purpose of this study is see how effective is JNJ-77242113 in participants with moderate to severe plaque psoriasis.
Active, not recruiting
Plaque Psoriasis
Drug: JNJ-77242113
Drug: Placebo
Locations recently updated
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Enrolling
Atopic Dermatitis
Drug: Rocatinlimab
Other: Placebo
The purpose of this study is to demonstrate that Super-Responders (SRe; defined as psoriasis participants who receive on-label guselkumab treatment u...
Active, not recruiting
Psoriasis
Drug: Guselkumab
Drug: Placebo Injection
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems